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Abstract
Background: During the recent Ebola outbreak, spraying of the environment and humans, including healthcare
workers, with chlorine was wide spread in affected African countries; adverse clinical effects are reported here.
Methods: A cross sectional survey by interview of 1550 volunteers consisting of 500 healthcare workers (HCW), 550
Ebola survivors (EVD) and 500 quarantined asymptomatic Ebola contacts (NEVD) was conducted. Demographics,
frequency of exposure to chlorine, clinical condition after chlorine exposure particularly eye, respiratory and skin
conditions were noted. The length of time HCWs worked in Ebola Treatment Units (ETU), and use of personal
protective equipment was recorded. Verbal consent was obtained from all participants and all responses remained
anonymous. Permission and assistance from the guardian or parent was sought for those below 18 years of age.
Results: 493/500 HCW, 550/550 EVD and 477/500 NEVD were sprayed at least once with 0 · 5 % chlorine. Following
even a single exposure, an increase in the number of eye (all three groups) and respiratory symptoms (in HCW &
EVD) was reported (p < 0 · 001); after multiple exposure, respiratory and skin symptoms increased. In HCW, multiple
vs single exposure was associated with an increase in respiratory (OR = 32 (95 % CI 22 –49) p < 0.001), eyes
(OR = 30 (95 % CI 21 –43) p < 0.001) and skin conditions (OR = 22 (95 % CI 15–32) p < 0.001). The available personal
protective equipment neither reduced nor prevented the adverse effects of chlorine.
Conclusion: Reported exposure to chlorine has usually been accidental. Despite the lack of evidence as a
recognised outbreak control measure, deliberate exposure of humans to chlorine spray was wide spread in Africa
during the Ebola epidemic resulting in serious detrimental health effects on humans. We strongly recommend that
this practice be banned and that alternative safer methods be used.
Keywords: Chlorine, Spray, Deliberate exposure, Humans, Healthcare workers, West Africa, Ebola, Infection control,
Decontamination, Adverse events, Side effects, Occupational exposure
Background
The 2014–2015 Ebola outbreak had a devastating impact
on Africa. The worst hit countries, Liberia, Sierra Leone
and Guinea reported more than 28646 cases of Ebola
and over 11,323 deaths [1]. Viral haemorrhagic fever
outbreaks are endemic in rural areas of West and East
Africa, and Ebola in particular reflects a close relation-
ship between human and non-human primates, living in
these forests [2, 3]. By the time the outbreak was offi-
cially recognised, many front line healthcare workers
(HCW), both from national and international organisa-
tions managing clinical cases of Ebola acquired the
disease. Of the 852 HCW who were diagnosed with
Ebola, 492 (58 %) died [1]. While HCW did their best to
contain the spread of Ebola, the lack of appropriate
training in infection prevention and control (IPC) and
inadequate resources led to a high mortality rate [4]. In-
fection prevention and control (IPC) guidance from vari-
ous organisations such as Centers for Disease Control
[5, 6] Médecins Sans Frontières [7], World Health
Organisation [8] amongst others, were rapidly deployed
and these documents were mainly based on experience
in other types of outbreaks such as cholera. The practice
of extensive spraying of 0.5 % chlorine on both animate
and inanimate objects, including humans who were
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either in direct, or indirect, contact with Ebola [6, 7] was
used despite WHO recommendations to the contrary
[8]. The IPC (Ebola) guidelines for West Africa con-
tained instructions to make up chlorine from powder or
liquid at concentrations of 0 · 5 % (5000 ppm) (for all
surface disinfection including human clothing) and 0 ·
05 % (500 ppm) chlorine for cleaning hands (http://
www.cdc.gov/vhf/ebola/hcp/mixing-chlorine-solutions.
html [9] and was part of the 3-day training for health-
care workers preparing to work in Ebola affected countries
(http://www.cdc.gov/vhf/ebola/hcp/safety-training-course/
training-toolkit.html) [10].
Chlorine based solutions have been widely used as
effective broad spectrum disinfectants for many years and
are widely available for both commercial and domestic
use; it is among the ten highest volume chemicals manu-
factured in the United States and is generally produced
under strictly controlled conditions. Chlorine is a noxious
substance especially in its gaseous form [11]. The symp-
toms of acute chlorine poisoning are well documented but
mainly from accidental exposure reports [12–14], which
require immediate medical attention. The main symptoms
are tightness of the chest [15], respiratory distress, visual
disturbance, loss of visual acuity [13]. Skin reactions such
as burning and dermatitis are noted following both acute
and chronic exposure to chlorine [5, 9],.
This study documents the adverse health effects result-
ing from deliberate chlorine spraying of humans (particu-
larly HCWs) during the Ebola outbreak in Sierra Leone.
Methods
A cross sectional survey was conducted between August
and November 2015 (4 months) interviewing 1550 vol-
unteers. The objective was to determine the adverse ef-
fects following known exposure to chlorine spray on
humans, with an aim to document prevalence of eye,
chest and skin conditions amongst the volunteers who
were interviewed and to determine whether chlorine was
a risk factor in the occurrence of these clinical
conditions.
Definitions used in this paper are as follows:
 Eye condition: defined as any sign or symptom
(pain, worse sight than before, painful eyes) that
occurred during the Ebola epidemic after exposure
to chlorine spray. Specific treatment and/or a visit to
the eye clinic were noted.
 Chest condition: Participants presenting with cough
(violent or not, producing sputum or not), burning
throat, chest tightness or difficulty in breathing,
after exposure to chlorine.
 Skin condition: was defined as skin irritation,
dermatitis, cracking or burning sensation after being
exposed to chlorine.
 Health care worker (HCW): included doctors,
nurses, lab technicians, community healthcare staff
and hygienists working in the ETUs and with
patients both in the healthcare facilities and in the
community.
 EVD Survivors (EVD): were those who were
declared Ebola free after recovering from the clinical
disease and usually confirmed as being Ebola
antibody negative.
 Non-EVD persons (NEVD): were those who did not
have clinical Ebola but were contacts of known or
suspected EVD cases and were under quarantine in
their homes.
The healthcare workers were actively involved in the
direct clinical care of Ebola cases. The hygienist cleaned
the healthcare facility, removed waste from the Red
Zone which was the part of the ETU were clinical cases
of Ebola were cared for. The other major job was spray-
ing other HCWs as they emerged from the Red Zone
and often with minimal protection.
The inclusion criteria were HCW, EVD and their con-
tacts who were quarantined (NEVD) and had been dir-
ectly sprayed with chlorine. Those who had no history of
direct chlorine spray exposure were excluded although it
was noted that some participants such as HCW and
NEVD were present when the surrounding environment
was sprayed because it was impossible to get away from
a total chlorine free environment. History of smoking
was recorded. No confounding factor was included in
the analysis, however, Ebola disease itself is known to
cause damage to the eyes and this was borne in mind.
One thousand five hundred and fifty volunteers were
recruited from one of the following three groups:
Healthcare workers (HCW) who were dealing with
clinical cases of Ebola (n = 500); survivors of either con-
firmed or suspected cases of clinical Ebola (EVD) (n = 550)
and finally those Ebola contacts with no clinical symptoms
at the time of interview but had been exposed to suspected
or confirmed cases of Ebola (NEVD) (n = 500) and were
under quarantine.
Two qualified nurses conducted interviews between
August and November 2015 (4 months). The partici-
pants were visited by one of the two interviewers, either
at the place of work (HCW), or at their residence (EVD
and NEVD groups) in the community They visited the
participants in rural, semi-urban and urban areas one
(SJ) worked with Ebola survivors (EVD) while the other
(HN) interviewed HCW and NEVD groups. A simple
yet exact questionnaire was devised which required
either a “yes/no” or “don’t know” answer; there were
neither open ended answers nor narrative responses.
The questionnaire was validated by a pilot study of 37
volunteers during an IPC training session in Sierra
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Leone in April 2015 where one of the interviewers was
present. After minor amendments, the questionnaire
was sent to the two interviewers to start collecting data.
The questionnaire covered demographics, the number
of exposures to chlorine spray, when and where they
were sprayed, and their state of health prior to being
sprayed. Of particular interest were eye symptoms such
as uveitis and loss of visual acuity which also constituted
part of clinical picture of Ebola, therefore the presence
of these symptoms prior to exposure were carefully re-
corded to establish that which was present prior to being
sprayed to try and differentiate between the two risk fac-
tors- (one of the authors (SJ) was a qualified ophthalmic
nurse practitioner). The replies were subjective but the
change in visual acuity was evaluated by clinical
examination.
Respiratory symptoms included tightness of the chest,
shortness of breath, irritation of the throat and cough-
ing, and skin conditions consisted of burning, cracking
of the skin, and dermatitis. For HCWs, the length of
time they worked in Ebola treatment units (ETU),
frequency and use of personal protective equipment was
recorded. Verbal consent was obtained from all
voluntary participants, and the responses remained
anonymous.
The demographic data was collected in larger age
groups according to where exposure would most likely
occur, for example either at the workplace or in the
community. Thus, unusually, the sample was divided
into age categories which were under the age of 18 years
(minors) mainly EVD survivors and the NEVD group
but not HCW; 19–35 years who constituted the younger
adult including HCWs and from the other two categor-
ies; 36–50 years as the older workforce including HCWs,
and over 50 years of age of whom fewer were employed
as HCWs. For those under the age of 18 years, permis-
sion and assistance from the guardian or parent to
complete the questionnaire was sought. During the
interview participants were asked to recall their experi-
ence before and after exposure to chlorine spray, the
number of times they were exposed and adverse effects
if any, they encountered after being sprayed.
The group who had not been sprayed were also inter-
viewed and their health condition was recorded however
those that had not been sprayed were excluded from the
final analysis.
The results were entered onto an Excel database and
analysed (AB) using Stata version 13 statistical package.
The forms remained in Sierra Leone and were available
at SM’s next visit.
The clinical syndromes- eyes, chest and skin condi-
tions, were dependent variables (binary). Demographics
and the frequency of spraying with chlorine represented
independent variables. Pearson Chi [2] was used to
compare proportions. Univariate logistic regression ana-
lyses were performed to determine the relationship be-
tween the dependent and the independent variables,
however multivariate analysis could not be performed.
The results of the logistic regression were presented as
odds ratio with their 95 % confidence intervals. The use
of PPE (HCW group) and the history of Ebola disease
(EVD group) were potential confounders.
Permission to conduct the study was obtained from
the Ministry of Health and Sanitation, Sierra Leone.
Results
A total of 1550 participants volunteered to be inter-
viewed of whom there were 550 Ebola survivors (EVD),
while HCW and NEVD community members made up
500 each; their recall of chlorine spray exposure was
vivid as some had been exposed quite recently and on
multiple occasions.
Of the 500 HCWs, nine were EVD survivors; one re-
ported becoming blind and another as partially blind
based upon clinical diagnosis from the eye clinic which
they were still attending. It was unclear whether this was
due to Ebola clinical disease or the chlorine spray but
most likely the former. They were included in the final
analysis because they had been sprayed. All HCWs were
working in the ETUs in the Red Zone where according
to the existing guidance, spraying of individuals and the
environment was carried out constantly on a daily basis.
Seven HCWs, (nurses =5, hygienist = 1, pharmacist =1)
had not been sprayed directly and were excluded from
the analysis, leaving 493 HCW questionnaires to be ana-
lysed. The clinical symptoms amongst these seven HCW
were minimal; one reported an unrelated previous eye
condition, another reported breathing difficulty plus a
tight chest as well as dermatitis; and a nurse reported
dermatitis. It is noteworthy that although not sprayed
directly, all seven of the HCWs worked in ETUs where
exposure to chlorine was a daily occurrence.
In the NEVD group, 23 persons were not sprayed with
chlorine directly; 14 were under the age of 7 years and
nine were between the ages of 22 and 30 years. There
were 477/500 (95.4 %) who had direct chlorine spray ex-
posure. Of the 23 NEVD who had not been exposed to
chlorine spray, none of them reported any of the clinical
conditions on the questionnaire. In the EVD group all
550 had been sprayed and were included in the final
analysis.
Demographics
The age distribution of the three groups that were ex-
posed to chlorine spray is shown in Table 1 and were
grouped into larger categories for convenience as de-
scribed above. The dominant age distribution in the
three groups was between 19 and 35 years. In the EVD
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survivor group 29 % where below the age of 18 years
and 93 % were over 50 years of age. For the NEVD
group, there were less than 3 % under the age of 18 years
and <1 % over 50 years. Approximately 99 % of HCW
were between the ages of 19–50 years. The majority of
the participants resided in rural districts. The gender
distribution is shown in Table 1 and reflects a predomin-
ance of males in the EVD and HCW groups and females
in the NEVD group.
Exposure to chlorine
The majority of HCWs interviewed were either hygien-
ists 231/493 (46.8 %) or nurses 224/493 (46 %); others
were community health officers (n = 4), doctors, district
social officers (n = 4), pharmacists (n = 6) and laboratory
technician (n = 17). Sixty eight percent had worked in
the ETUs for 4–6 months, and 28 % had been there for
7–8 months; 3 % were working in ETUs for 9–12
months. Single and multiple exposure was reported by
285/493 (58 %) in 208/493 (42 %) HCW respectively.
EVD survivors were sprayed on a single occasion in 292/
550 (53 %) and multiple exposure in 258/550 (47 %).
When and where sprayed
The recommended chlorine strength used for spraying
was 0.5 % but there was no means of establishing the
exact concentration of the mixture. No quantity was de-
fined- spraying continued until the persons were totally
soaked and all visible organic matter was washed away.
This occurred each time there was any exposure to sus-
pected or confirmed case of Ebola. Ninety two percent
of the HCWs were sprayed when leaving the ETU, but
they were also exposed when spraying others (23.5 %),
or were present when others were being sprayed
(23.6 %); some were sprayed in their own homes, or
when visiting community dwellings (Table 2).
Of the EVD survivors, 99.5 % reported being sprayed
either prior to or during, transportation in the back of
an ambulance with sealed windows and doors en route
to the ETU- a trip that could last for 3 h in high temper-
atures. Those under quarantine (NEVD) were sprayed at
home, but some were sprayed before transportation
while others (8 %) were sprayed in the back of the am-
bulance during transportation (Table 2).
Reported clinical adverse effects
Adverse events were reported by all three groups, albeit
subjective, as defined in the methods section for eye, re-
spiratory and skin conditions. Following a single chlor-
ine exposure, significant increase in eye symptoms was
reported in all three groups (p < 0.001), but the EVD sur-
vivors had the highest number of eye symptoms prob-
ably related to their clinical disease (Table 3).
Respiratory symptoms were similar for EVD and HCW,
and exceeded NEVD in significance (p < 0.001); skin irri-
tation was highest amongst the HCW (33 · 6 %) (Table 3)
and the use of 0.05 % chlorine used for washing hands
could have contributed towards these symptoms.
Multiple exposure to chlorine was reported by EVD
and HCW groups (Table 4). Pre-chlorine exposure eye
symptoms were present in both EVD (19 · 4 %) and
HCW (12 · 1 %) which increased to 64 and 59 · 1 % re-
spectively post exposure, however this was not found to
be statistically significant (p < 0.3). Following multiple
exposure, respiratory tract symptoms such as difficulty
in breathing, tightness in the chest and burning in the
throat (p < 0 · 001) were more significant amongst HCWs
(Table 4). Skin conditions were significantly higher in
the HCW group, possibly due to extensive repeated
exposure to chlorine (0.05 %) used for hand washing in
the ETU.
Table 1 Distribution of age, gender and residential areas for the
three interview groups
Age (years) EVD
N (550) n (%)
Non EVD
N (477) n (%)
HCW
N (493) n (%)
P-value
<1 year 4 (0 · 7) 1 (0 · 2) <0.001
2–18 155 (28 · 2) 12 (2 · 5)
19–35 236 (42 · 9) 451 (94 · 5) 371 (75 · 4)
36–50 104 (18 · 9) 10 (2 · 1) 118 (23 · 8)
50+ 51 (9 · 3) 3 (0 · 6) 4 (0 · 8)
Male 225 (50) 78 (16 · 35) 273 (55 · 6) <0.001
Smoking 201 (36 · 5) 35 (73) 38 (7 · 7) <0.001
Urban 50 (9) 190 (40) 74 (15)
Table 2 Chlorine spraying in the three groups
Site HCW EVD NEVD
Total interviewed 500 550 500
Not sprayed (excluded) 7 0 23
Total analysed N = 493 % N = 550 % N = 477 %
In own house
(under quarantine)
9 2 0 - 440 0 92
Outside in the community 0 - 0 - 21 4
Pre transfer 0 - 162 30 15 3
Back of ambulance 61 12 547 99 38 8 · 0
Leaving ETU 550 100
Red zone 455 93 120 22
Spray others 113 23
In room when spraying others 116 24
EVD case house 16 3
EVD suspect house 33 7
HCW = healthcare workers; EVD = Ebola virus disease survivors; NEVD = non
Ebola cases
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For HCW, the clinical effect of multiple versus single
exposure was documented. There was a significant
increase in eye symptoms amongst those who had had
multiple exposure increasing from 33 · 6 to 59 · 1 %
(p < 0.001) and statistically significant increase in chest
and skin conditions (Table 5). There was also an increase
in the odds of chest condition (OR = 3.2 (95 % CI 2.0–
4.9) p < 0.001), deterioration of their eyes (OR = 3.3
(95 % CI 2.2–5) p < 0.001) and skin condition (OR = 2.4
(95 % CI 1.6–3.6), p < 0.001) occurrence (unadjusted lo-
gistic regression) in the multiple exposure group. It was
noteworthy that 57 · 5 % (184/320) of HCW with a chest
condition also had an eye condition. There was no
statistical significant difference between single and mul-
tiple exposure in the EVD group.
Always wearing eye protection during spraying was re-
ported by 82 · 2 % (410/500), sometimes 14.6 % (73/500)
or never 3.2 % (16/500), of HCWs. Skin protection
(gloves and coverall) was worn 90 · 6, 9, and 0 · 4 % re-
spectively for always, sometimes or never (Table 6).
HCWs were more likely to wear skin protection, than
eye protection (goggles or shields). Overall, 64 % of
HCW reported chest conditions, and 48 % had eye
problems following exposure. Despite the use of PPE,
respiratory symptoms were reported by the nurses
(p < 0.05) and skin conditions by the hygienists
(p < 0.001) suggesting that wearing PPE did not protect
HCW from adverse events of chlorine (Table 6).
Limitations
The data was collected retrospectively towards the end
of the EVD outbreak and the responses relied on mem-
ory of the participants. Most of them had vivid memor-
ies of being sprayed and the consequences. There was
no shortage of volunteers to participate in the interviews
and the sample could have been much larger, however
the financial constraints limited the study to 1550 re-
spondents. The study was conducted in the rural and
semi urban districts of Sierra Leone and there was a
limitation on travel and free movement at the time and
so the interviewers were confined to their areas of resi-
dence and work.
The effect of Ebola on the eyes is well documented. In
the EVD group it was difficult to establish the before
and after adverse events attributable to chlorine alone.
However, the NEVD and HCW who had not been in-
fected provided a sizeable sample in this regard. Those
presenting to the eye clinic for treatment provided a
Table 3 The clinical effects of single exposure amongst EVD,
NEVD and HCW
Characteristic of single
chlorine exposure
EVD
(N = 292)
n (%),
HCW
(N = 285)
n (%)
NEVD
(N = 477)
n (%)
P-value
Eye sight problem before 55 (19) 19 (7) 38 (8) <0 · 001
Eye sight problem now 185 (63) 95 (34) 55 (12) <0 · 001
Coughing 107 (37) 107 (38) 39 (8) <0 · 001
Cough producing sputum 76 (26) 43 (15) 17 (4) <0 · 001
Difficulty in breathing 86 (30) 66 (23) 24 (5) <0 · 001
Chest tightness 100 (34) 109 (38) 30 (6) <0 · 001
Burning throat 87 (30) 85 (30) 30 (6) <0 · 001
Skin irritation 11 (4) 95 (34) 86 (18) <0 · 001
Table 4 Multiple chlorine exposure effect on EVD and HCW
compared
Characteristic of multiple exposure EVD
(N = 258)
n (%),
HCW
(N = 208)
n (%)
P-value
Eye sight problem before 50 (19) 25 (12) 0 · 04
Eye sight problem now 165 (64) 123 (59) 0 · 3
Coughing 89 (35) 124 (60) <0 · 001
Cough producing sputum 76 (30) 60 (29) 0 · 99
Difficulty in breathing 93 (36) 100 (48) 0 · 009
Chest tightness 92 (36) 131 (62 · 9) <0 · 001
Burning throat 80 (31) 112 (54) <0 · 001
Skin irritation 10 (4) 109 (52) <0 · 001
Table 5 Adverse events in HCW with single and multiple
chlorine exposure compared
Characteristic Single Cl2
exposure
(N = 285) n(%),
Multiple Cl2
exposure
(N = 208) n(%)
P-value
Eye sight problem before 19 (7) 25 (12) 0.04
Eye sight problem now 95 (34) 123 (59) <0 · 001
Coughing 107 (38) 124 (60) 0 · 001
Cough producing sputum 43 (15) 60 (29) <0 · 001
Difficulty in breathing 66 (23) 100 (48) <0 · 001
Chest tightness 109 (38) 131 (63) <0 · 001
Burning throat 85 (30) 112 (54) <0 · 001
Skin irritation 95 (34) 109 (52) <0 · 001
Table 6 Category of staff and use of PPE and adverse events
reportedDSO district social officer, CHO community health officer
Job categories
n = 293
Eye PPE Skin PPE Clinical symptoms
Categories n Always not
always
always not
always
eye chest skin
Doctor 7 5 2 5 2
Nurse 224 183 41 199 25 ns 0 · 05 ns
Hygienist 231 188 42 213 18 ns ns 0 · 001
Pharmacist 6 5 1 5 1
DSO 4 3 1 4 0
CHO 4 4 0 4 0
Lab technician 17 16 1 16 1
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better insight into the clinical symptoms. Those that re-
ported chest symptoms but these were absent at the
time of interview, the interviewer recorded their replies.
The presence of skin conditions were confounded by the
use of 0.05 % chlorine for hand washing which the health-
care workers and community populations used frequently.
Finally, because the use of chlorine was widespread, it
was difficult to find a large enough control sample size
that had not been exposed to chlorine to be able to carry
out a case- control study.
Discussion
This Ebola outbreak was the largest recorded thus far in
Africa and occurred outside the previously known range
for the Ebola virus [1]. The rapid uncontrolled spread
from rural to urban areas led to some highly unconven-
tional containment practices, such as the widespread
spraying of 0.5 % chlorine, which exposed many of the
community and HCWs, to a noxious chemical sub-
stance. In the two separate CDC guidelines for dealing
with Ebola, one for the West Africa (non- US healthcare
settings) [6] http://www.cdc.gov/vhf/ebola/hcp/non-us-
healthcare-settings.html and the other for the United
States healthcare facilities [16] http://www.cdc.gov/vhf/
ebola/healthcare-us/index.html recommendations on
disinfection and the use of disinfectants were different.
In the non- US healthcare settings, chlorine was clearly
advocated as the disinfectant of choice and it states
“Correctly mixed and applied, chlorine solutions will
damage Ebola virus on personal protective equipment
(PPE) and other surfaces so that it can no longer infect
patients and healthcare workers”. http://www.cdc.gov/
vhf/ebola/hcp/non-us-healthcare-settings.html [6]. In
the guidelines for the United States, EPA approved disin-
fectants are recommended for the disinfection of the
environment but there is neither specific mention of the
use of chlorine nor of application to PPE and spraying of
individuals for personal protection (http://www.cdc.gov/
vhf/ebola/healthcare-us/index.html) [16]. In our study,
in Sierra Leone, like other EVD affected countries, 0.5 %
chlorine was widely used to spray environmental
surfaces and humans in contact with suspected or con-
firmed cases of Ebola, including HCWs while wearing
their PPE as they emerged from the Red Zone in ETUs
or from community dwellings.
Most accounts of chlorine exposure in humans have
been accidental usually following transportation, explo-
sion, inaccurate chlorine mixing, or mechanical malfunc-
tion releasing large amounts of chlorine vapour which is
inhaled [11–14].
Occupational health authorities including the WHO
[17], clearly define chlorine spray exposure as a liquid or
gas as being toxic to humans particularly eye, respiratory
system and skin [11, 18]. The principal targets of
exposure to chlorine gas are the respiratory airways and
the eyes. Exposure can occur only by direct contact of
inhaled chlorine gas with the respiratory epithelium [19]
or via direct contact of the eyes and skin which causes
excessive irritation and corneal ulceration [11]; acciden-
tal over-chlorination of swimming pools is one type of
reported exposure affecting children and adults [11].
A review by D’Alessandro and colleagues [20] reported
sensory irritation, and transient pulmonary changes in
humans exposed to 1 ppm chlorine causing increased
airway resistance and reduced air flow. Yildirim et al.
[21] reported morphological alteration in nasal mucosa
of rats with loss of cilia and nasal epithelium at concen-
trations of >5 ppm chlorine.
While our findings are self-reported adverse effects in
those who had been exposed to chlorine in the rural and
semi urban districts, the number of participants report-
ing respiratory, skin and eye symptoms particularly
amongst healthcare workers who were exposed was sig-
nificant. This exposure could have been avoided if the
use of chlorine had been better regulated and controlled
and occupational exposure limits are strictly complied
with during production or reconstitution [11, 18]. Anec-
dotal evidence suggests that the concentrations of chlor-
ine were higher than recommended because of two
reasons: often the measurements were inaccurate, and
those that were making up the solutions thought a
stronger solution would be more effective. If the teams
dealing with Ebola were not adequately trained or were
unprepared, the excessive use of chlorine was possibly
out of fear of contracting the disease [9].
To our knowledge this is the first report of deliberate
exposure of humans to chlorine as part of disinfection
practices. Our study showed that even a single exposure
to 0.5 % chlorine caused ocular, respiratory and skin irri-
tation (Table 3). The frequency of single vs multiple
exposure as noted in EVD and HCW groups signifi-
cantly increased the risk of respiratory and skin irritation
particularly in HCWs (Table 4). It is noteworthy, that
the use of the available personal protective equipment
for HCWs did not have any impact on the adverse
effects of chlorine (Table 6) and the use of the currently
available PPE is called into question by some colleagues
working in the field [22].
Of concern was that participants (21/362 (5.8 %)) said
they knew of someone who had been sprayed and trans-
ported in a closed non ventilated ambulance to an ETU
up to 3 h away and was pronounced dead on arrival
without a confirmed diagnosis of Ebola; this raises ques-
tions about the number of deaths attributed to Ebola
which could have been due to other causes.
Chlorine is a widely used disinfectant and can be
effectively used in appropriate circumstances for the
correct indications. It should be applied as a wipe rather
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than a spray, the latter causing aerosolization which can
cause respiratory symptoms and irritation of the eyes
and the skin.
Conclusion
Our results point to two main findings; firstly, there was
a statistically significant increase in the clinical symp-
toms of HCW when they were exposed multiple times
to chlorine spray. The use of chlorine to disinfect
personal protective equipment while HCW are wearing
it is not only without evidence, ineffectual but can be
hazardous to health [11]. Secondly, the available PPE
that was used by HCW did not protect them against the
adverse effects of chlorine spray [17]. This was because
when chlorine is inhaled it converts to hydrochloric acid
in the respiratory tract and causes severe clinical symp-
toms [19, 20, 23].
We strongly recommend that the spraying of humans
with chlorine is banned forthwith; however, appropriate
concentration of chlorine may be used for environmen-
tal disinfection when recommended by IPC teams.
Should chlorine be indicated for disinfection, it should
be applied as a wipe rather than a spray. Alternatives
such as 70 % alcohol should be considered.
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